MA71600A - Nouveaux dérivés d'indole sulfonamide substitués en position 7 - Google Patents
Nouveaux dérivés d'indole sulfonamide substitués en position 7Info
- Publication number
- MA71600A MA71600A MA71600A MA71600A MA71600A MA 71600 A MA71600 A MA 71600A MA 71600 A MA71600 A MA 71600A MA 71600 A MA71600 A MA 71600A MA 71600 A MA71600 A MA 71600A
- Authority
- MA
- Morocco
- Prior art keywords
- sulfonamide derivatives
- derivatives substituted
- new indole
- indole sulfonamide
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22187363 | 2022-07-28 | ||
| PCT/EP2023/070657 WO2024023128A1 (fr) | 2022-07-28 | 2023-07-26 | Nouveaux dérivés d'indole sulfonamide substitués en position 7 |
| EP23748060.3A EP4562003A1 (fr) | 2022-07-28 | 2023-07-26 | Nouveaux dérivés d'indole sulfonamide substitués en position 7 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA71600A true MA71600A (fr) | 2025-05-30 |
Family
ID=82748322
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA71600A MA71600A (fr) | 2022-07-28 | 2023-07-26 | Nouveaux dérivés d'indole sulfonamide substitués en position 7 |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP4562003A1 (fr) |
| JP (1) | JP2025524062A (fr) |
| KR (1) | KR20250043398A (fr) |
| CN (1) | CN119585257A (fr) |
| AR (1) | AR130023A1 (fr) |
| AU (1) | AU2023315120A1 (fr) |
| CA (1) | CA3261059A1 (fr) |
| CL (1) | CL2025000125A1 (fr) |
| CO (1) | CO2025002033A2 (fr) |
| CR (1) | CR20250018A (fr) |
| IL (1) | IL316865A (fr) |
| MA (1) | MA71600A (fr) |
| MX (1) | MX2025000822A (fr) |
| PE (1) | PE20250849A1 (fr) |
| TW (1) | TW202412800A (fr) |
| WO (1) | WO2024023128A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2700773A (en) | 2024-05-23 | 2026-03-11 | Pheno Therapeutics Ltd | Compounds |
| GB2701173A (en) | 2024-05-23 | 2026-04-22 | Pheno Therapeutics Ltd | Compounds |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3584244A1 (fr) * | 2018-06-20 | 2019-12-25 | UCB Pharma GmbH | Indolsulfonamides alkoxypyridinyl substitués |
| JP2024507176A (ja) * | 2021-02-26 | 2024-02-16 | エフ. ホフマン-ラ ロシュ アーゲー | 新規なピリミジン-2-イルスルホンアミド誘導体 |
-
2023
- 2023-07-26 EP EP23748060.3A patent/EP4562003A1/fr active Pending
- 2023-07-26 CN CN202380055096.9A patent/CN119585257A/zh active Pending
- 2023-07-26 WO PCT/EP2023/070657 patent/WO2024023128A1/fr not_active Ceased
- 2023-07-26 CA CA3261059A patent/CA3261059A1/fr active Pending
- 2023-07-26 IL IL316865A patent/IL316865A/en unknown
- 2023-07-26 AU AU2023315120A patent/AU2023315120A1/en active Pending
- 2023-07-26 AR ARP230101952A patent/AR130023A1/es unknown
- 2023-07-26 PE PE2025000192A patent/PE20250849A1/es unknown
- 2023-07-26 CR CR20250018A patent/CR20250018A/es unknown
- 2023-07-26 JP JP2025504084A patent/JP2025524062A/ja active Pending
- 2023-07-26 KR KR1020257001777A patent/KR20250043398A/ko active Pending
- 2023-07-26 MA MA71600A patent/MA71600A/fr unknown
- 2023-07-27 TW TW112128105A patent/TW202412800A/zh unknown
-
2025
- 2025-01-15 CL CL2025000125A patent/CL2025000125A1/es unknown
- 2025-01-21 MX MX2025000822A patent/MX2025000822A/es unknown
- 2025-02-24 CO CONC2025/0002033A patent/CO2025002033A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PE20250849A1 (es) | 2025-03-21 |
| KR20250043398A (ko) | 2025-03-28 |
| AR130023A1 (es) | 2024-10-23 |
| CA3261059A1 (fr) | 2024-02-01 |
| EP4562003A1 (fr) | 2025-06-04 |
| CN119585257A (zh) | 2025-03-07 |
| TW202412800A (zh) | 2024-04-01 |
| IL316865A (en) | 2025-01-01 |
| CO2025002033A2 (es) | 2025-03-17 |
| AU2023315120A1 (en) | 2024-11-14 |
| CR20250018A (es) | 2025-03-03 |
| CL2025000125A1 (es) | 2025-05-23 |
| MX2025000822A (es) | 2025-03-07 |
| WO2024023128A1 (fr) | 2024-02-01 |
| JP2025524062A (ja) | 2025-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA71601A (fr) | Nouveaux dérivés d'indole sulfonamide substitués en position 7 | |
| MA71600A (fr) | Nouveaux dérivés d'indole sulfonamide substitués en position 7 | |
| CY1109656T1 (el) | Υποκατεστημενα παραγωγα μορφολινης και θειομορφολινης | |
| TW200738607A (en) | Sulfonamide derivatives, preparation thereof and therapeutic use thereof | |
| FR15C0062I2 (fr) | Nouveaux derives d'oxazolidinone | |
| CO5640093A2 (es) | Derivados n-n` sustituidos de 1.3 diamino-2-hidroxipropano | |
| CY1110651T1 (el) | Παραγωγα της ν-'(1,5-διφαινυλ-1η- πυραζολ-3-υλ)μεθυλ σουλφοναμιδης με μια συγγενεια για τους υποδοχεις cb1 | |
| CY1105299T1 (el) | Χρηση των επιλεκτικων αγωνιστων του υποδοχεα 4 (ep4) προσταγλανδινης (pge2) για τη θepαπεια της οξειας και χρονιας νεφρικης ανεπαρκειας | |
| ATE383856T1 (de) | (4-hydroxyphenyl)-1h-indol-3-carbaldehydoxim- derivative als östrogenagentien | |
| DK2314582T3 (da) | Heterocykliske forbindelser som antivirusmidler | |
| BRPI0412257A (pt) | compostos para inflamação e usos imuno-relacionados | |
| DE60024115D1 (de) | Pharmazeutisch wirksamer sulfonamid derivaten | |
| ATE316977T1 (de) | Neue pseudoerythromycin derivate | |
| CY1106471T1 (el) | Νεα μεθοδος συνθεσης της περινδροπριλης και των φαρμακευτικως αποδεκτων αλατων αυτης | |
| ATE459598T1 (de) | Sulfonamidderivate | |
| EP4332184A4 (fr) | Kit d'encre | |
| EP4038433A4 (fr) | Conceptions d'objectif de macrotélévision pliée | |
| EP4621179A4 (fr) | Charnière dissimulée | |
| CA3263179A1 (fr) | Nouveaux inhibiteurs de l'acc | |
| DK1513806T3 (da) | Sulfonsyresalte af sulfonsyrederivater | |
| UY27074A1 (es) | Derivados de aminotriazolopiridina | |
| DK1658062T3 (da) | Alfa-aminoamid-derivater anvendelige som anti-inflammatoriske midler | |
| NO20023380D0 (no) | Indolderivater som MCP-1-reseptoragonister | |
| EP1855651A4 (fr) | Compositions nanoparticulaires de derives d'amide heterocyclique | |
| MA71620A (fr) | Formulations d'anticorps anti-tl1a |